Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Job's tear (Coix lacryma-jobi) is a whole grain cereal being investigated by Taipei Veterans General Hospital, Taiwan, for its potential health benefits. A randomized controlled trial is evaluating the efficacy of Taiwanese whole grain job's tear, specifically comparing red and white varieties, on muscle health, blood glucose, and lipid levels in older adults exhibiting signs of sarcopenia or frailty. [22] The grain is known to contain a variety of bioactive compounds, including polysaccharides, polyphenols, lipids, and phytosterols. [21, 34] These components are believed to contribute to its observed health effects, which include anti-inflammatory, antioxidant, immunomodulatory, anti-diabetic, and hypolipidemic properties. [27, 31, 33, 35]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Coix lacryma-jobi.